Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
शेयरों में रैंक #11774
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
शेयर मूल्य
$1.77
अंतिम समन्वयन: 2026-08-28
मार्केट कैप
$660.45M
बदलाव (1 दिन)
7.26%
बदलाव (1 वर्ष)
-9.15%
देश
AU
व्यापार Clarity Pharmaceuticals Ltd (CU6)

श्रेणी

Clarity Pharmaceuticals Ltd (CU6) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $1.83 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $1.06 (2021-08-01 को)
Clarity Pharmaceuticals Ltd के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 4.14%
2025 -32.14%
2024 182.71%
2023 71.64%
2022 17.37%
2021 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$233.52 -4.71%
IE
$15.30 -23.07%
CN
$520.74 6.34%
CH
$164.39 -9.49%
CH
$2.30 -28.59%
CN